Natural autoantibodies as tools to predict the outcome of immune response?

Scandinavian Journal of Immunology

Volumn 58, Issue 3, 2003, Pages 285-289

  Kohler, H ^a,c   Bayry, J ^b   Nicoletti, A ^b   Kaveri, S V ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b INSERM   (France)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; CD5 ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VACCINE;

AUTOREGULATION; B LYMPHOCYTE; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; IMMUNOGLOBULIN BLOOD LEVEL; INFLAMMATORY DISEASE; NONHUMAN; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; REVIEW; SCREENING; T LYMPHOCYTE;

AUTOANTIBODIES; AUTOANTIGENS; B-LYMPHOCYTES; HUMANS; IMMUNITY, NATURAL; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 0041410001     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2003.01314.x     Document Type: Review

References (36)

1. Hayakawa K, Asano M, Shinton SA et al. Positive selection of natural autoreactive B cells. Science 1999;285:113-6.
2. Avrameas S, Ternynck T. The natural autoantibodies system: between hypotheses and facts. Mol Immunol 1993;30:1133-42.
3. Casali P, Kasaian MT, Haughton G. B-1 (CD5 B) cells. In: Coutinho A, Kazatchkine MD, eds. Autoimmunity: physiology and disease. New York: Wiley-Liss, 1994, 57-88.
4. Kazatchkine MD, Kaveri SV. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med 2001;345:747-55.
5. Avrameas S. Natural autoantibodies: from 'horror autotoxicus' to 'gnothi seauton'. Immunol Today 1991;12:154-9.
6. Kantor AB, Herzenberg LA. Origin of murine B cell lineages. Annu Rev Immunol 1993;11:501-38.
7. Kaveri SV, Kang CY, Kohler H. Natural mouse and human antibodies bind to a peptide derived from a germline variable heavy chain: evidence for evolutionary conserved self-binding locus. J Immunol 1990;145:4207-13.
8. Hurez V, Kaveri SV, Kazatchkine MD. Expression and control of the natural autoreactive IgG repertoire in normal human serum. Eur J Immunol 1993;23:783-9.
9. Kaveri S, Vassilev T, Hurez V et al. Antibodies to a conserved region of HLA class I molecules, capable of modulating CD8 T cell-mediated function, are present in pooled normal immunoglobulin for therapeutic use (IVIg). J Clin Invest 1996;97:865-9.
10. Prasad N, Papoff G, Zeuner A et al. Therapeutic preparations of normal polyspecific immunoglobulin G (IVIg) induce apoptosis in human lymphocytes and monocytes: a novel mechanism of action of IVIg involving the Fas apoptotic pathway. J Immunol 1998;161:3781-90.
11. Vassilev T, Kazatchkine MD, Duong Van Huyen JP et al. Inhibition of cell adhesion by antibodies to Arg-Gly-Asp (RGD) in normal immunoglobulin for therapeutic use (intravenous immunoglobulin, IVIg). Blood 1999;93:3624-31.
12. Bouhlal H, Hocini H, Quillent-Gregoire C et al. Antibodies to C-C chemokine receptor 5 in normal human IgG block infection of macrophages and lymphocytes with primary R5-tropic strains of HIV-1. J Immunol 2001;166:7606-11.
13. Lieberman R, Potter M, Mushinski EB, Humphrey W, Rudikoff S. Genetics of a new IgVh (T-15 idiotype) marker in the mouse regulating natural antibody to phosphorylcholine. J Exp Med 1974;139:983-90.
14. Lee W, Cosenza H, Kohler H. Clonal restriction of the immune response to phosphorylcholine. Nature 1974;247:55-8.
15. Briles D, Nahm M, Schroer K et al. Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 streptococcus pneumoniae. J Exp Med 1981;153:694-705.
16. Szu S, Clarke S, Robbins JB. Protection against pneumococcal infection in mice conferred by phosphocholine-binding antibodies: specificity of the phosphocholine binding and relation to several types. Infect Immun 1983;39:993-9.
17. Bondada S, Bikah G, Robertson DA, Sen G. Role of CD5 in growth regulation of B-1 cells. Curr Top Microbiol Immunol 2000;252:141-9.
18. Briles DE, Forman C, Hudak S, Claflin JL. The effects of idiotype on the ability of IgG1 anti-phosphorylcholine antibodies to protect mice from fatal infection with Streptococcus pneumoniae. Eur J Immunol 1984;14:1027-30.
19. Lim PL, Choy WF, Chan ST, Leung DT, Ng SS. Transgene-encoded anti-phosphorylcholine (T 15+) antibodies protect CBAIN (xid) mice against infection with Streptococcus pneumoniae but not Trichinella spiralis. Infect Immun 1994;62:1658-61.
20. Nawata Y, Stall A, Herzenberg L, Eugui E, Allison A. Surface immunoglobulin ligands and cytokines differentially affect proliferation and antibody production by human CD5+ and CD5-B lymphocytes. Intern Immunol 1990;2:603-14.
21. Flick K, Scholander C, Chen Q et al. Role of nonimmune IgG bound to PfEMP1 in placental malaria. Science 2001;293:2098-100.
22. Ochsenbein AF, Fehr T, Lutz C et al. Control of early viral and bacterial distribution and disease by natural antibodies. Science 1999;286:2156-9.
23. Carroll MC. The role of complement and complement receptors in the induction and regulation of immunity. Annu Rev Immunol 1998;16:545-68.
24. Ochsenbein A, Zinkernagel RM. Natural antibodies and complement link innate and acquired immunity. Immunol Today 2000;21:624-30.
25. Kaveri SV, Halpern R, Kang CY, Kohler H. Self-binding antibodies (autobodies) form specific complexes in solution. J Immunol 1990;145:2533-8.
26. Kondo T, Cortese I, Markovic-Plese S et al. Dentritic cells signal T cell in the absence of exogenous antigen. Nat Immunol 2001;2:932-8.
27. Revy P, Sospedra M, Barbour B, Trautmann A. Functional antigen-independent synapses formed between T cells and dentritic cells. Nat Immunol 2001;2:925-31.
28. Baumgarth N, Herman OC, Jager GC, Brown LE, Herzenberg LA, Chen J. B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J Exp Med 2000;192:271-80.
29. Boes M, Esau C, Fischer MB, Schmidt T, Carroll M, Chen J. Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in secreted IgM. J Immunol 1998;160:4776-87.
30. Ehrenstein M, O'Keefe TL, Davies SL, Neuberger MS. Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response. Proc Natl Acad Sci USA 1998;95:10089-93.
31. Kipps TJ. The CD5 B Cell. Adv Immunol 1989;47:117-85.
32. Berland R, Wortis HH. Origins and functions of B-1 cells with notes on the role of CDS. Annu Rev Immunol 2002;20:253-300.
33. Carroll MC, Prodeus AP. Linkages of innate and adaptive immunity. Curr Opin Immunol 1998;10:36-40.
34. Rodman TC, To SE, Sullivan JJ, Winston R. Innate natural antibodies. Primary roles indicated by specific epitopes. Human Immunol 1997;55:87-95.
35. Tsuji RF, Szczepanik M, Kawikova I et al. B cell-dependent T cell responses: IgM antibodies are required to elicit contact sensitivity. J Exp Med 2002;196:1277-90.
36. Kohler H, Kaveri SV, Kazatchkine MD, Kieber-Emmons T. Clonal selection theory - revisited. The Immunologist 2000;8:91-3.